March 6 (Reuters) - The global weight-loss drug market is entering a new phase, driven by the arrival of oral options, looming generic rivals and falling U.S. prices for blockbuster treatments from ...

A Wegovy weight loss pill could soon be a reality after tests showed taking the once-daily oral medication was about as successful at helping people lose weight as its injectable form. People who were ...

The weight-loss drug Wegovy is now being sold in pill form, an advancement that allows users to transition away from weekly injections. It's the first GLP-1 weight-loss medication to become available ...

Our collective appetite for weight loss drugs has become pretty much insatiable over the past few years. It’s thought that around 1.5 million people in the UK are on GLP-1 agonist medications to curb ...

Orforglipron, which could be approved for obesity next quarter, proved superior at cutting blood sugar and body weight — but at the expense of higher side effect rates.

For decades, researchers have been looking for an effective weight-loss pill. But the recent success of glucagon-like peptide-1 (GLP-1) weight-loss injections has sparked new hope — especially for ...

A Wegovy pill is now available in pharmacies nationwide. The weight loss medication is an alternative to GLP-1 injections. Below, a weight loss expert shares what you need to know. Wegovy—a medication ...

Eli Lilly and Company (NYSE: LLY) has stockpiled $1.5 billion worth of inventory of its experimental oral weight-loss drug, orforglipron, according to a regulatory filing on Thursday. This significant ...

Each year, millions of people turn to diet pills to lose weight. As of 2022, about 15 percent of U.S. adults reported using a weight-loss supplement at some point in their lives. One popular ...

The global weight-loss drug market is entering a new phase, driven by the arrival of oral options, looming generic rivals and falling U.S. prices for blockbuster treatments from Eli Lilly and Novo ...